BioPharmaTrend
Latest News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers

Peter Jarowski

     


Professor of Chemistry, Ph. D.
CEO/Co-founder at ChemAlive SA - Quantum Chemistry for All

Peter is an expert in the application of computational methods to molecular design. After NYU (B. Sc.), UCLA (Ph. D.), ETH, EPFL and as a former professor of chemistry, he has the vision to achieve reliable, meaningful chemical predictions without the hassle of the technical aspects of computational chemistry.

Contributing Author

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Latest articles from Peter


ConstruQt – The Beginnings of the Chemical Data Revolution

Feb. 4, 2020   
ConstruQt – The Beginnings of the Chemical Data Revolution

Chemical Data Has Problems

The state of data access, quality and dissemination in Chemistry is extremely poor - so poor that it is blocking advances in machine learning (ML) and artificial intelligence (AI), and also impeding research and development in …

A Reliable Molecular Structure Predictor in the Cloud

Dec. 17, 2018   
A Reliable Molecular Structure Predictor in the Cloud

Since August Kekulé’s proposal for the tetrahedral configuration of carbon or his more famous realization that benzene was a cyclic molecule, a snake biting its tale, molecular structure has been the leading consideration for the design of new molecules as …

[White paper] High Throughput Quantum Chemistry for Drug Discovery - Towards Reaction Screening

Feb. 15, 2018   
[White paper] High Throughput Quantum Chemistry for Drug Discovery - Towards Reaction Screening

In the domain of drug discovery, there can be a world of difference between a computer-generated hit compound, which is predicted to bind well to a drug target and what can be reliably synthesized at scale, or indeed synthesized at …

#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.